Activation of telomerase in BeWo cells by estrogen and 2,3,7,8-tetrachlorodibenzo-p-dioxin in co-operation with c-Myc.
Telomerase activation, known to be stimulated by estrogen, is essential for cellular immortalization and trans-formation, both of which play a role in tumorigenesis. Dioxin and dioxin-like compounds have been shown to induce endometriosis and promote estrogen-dependent tumors. In this study, we show that either 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or a combination of TCDD and 17-beta estradiol (E2) increase telomerase activity and the expression of the human telomerase catalytic subunit (hTERT) in human choriocarcinoma (BeWo) cells. Compared with estrogen or TCDD alone, the combination treatment did not show an additive effect. Likewise, treatment with either E2 or TCDD increased DNA synthesis and the cell population in S-phase, as detected by FACS analysis. However, following treatment with the E2 and TCDD combination, the proportion of cells in S-phase was actually lower than in cells treated with TCDD alone. These results suggest that TCDD alone mimics estrogenic action in telomerase activation and cell proliferation but, in the presence of estrogen, TCDD-induced actions were partially counteracted. E2 and TCDD also induced c-Myc, which is a transcriptional activator of hTERT in Bewo, but neither of these agents induced telomerase activity in HO15.19 c-myc-null cells. In contrast, only TCDD upregulated telomerase in TGR-1 cells, which are c-Myc expressing but lacking ER expression. The findings suggest that TCDD induces telomerase activity mediated through AhR signaling and/or ER-independent c-Myc signaling. The present study provides insight into the mechanism of promoter activity of TCDD in estrogen-related tumors.
Sarkar
Poonam
P
Endocrine Disruptors and Dioxin Research Project, National Institute for Environmental Studies, Tsukuba 305-8506, Japan.
Shiizaki
Kazuhiro
K
Yonemoto
Junzo
J
Sone
Hideko
H
D002822:Choriocarcinoma / Q000139:chemically induced* / Q000235:genetics* / Q000473:pathology; D004268:DNA-Binding Proteins / Q000378:metabolism; D004789:Enzyme Activation; D004958:Estradiol / Q000502:physiology*; D005260:Female; D006801:Humans; D000072317:Polychlorinated Dibenzodioxins / Q000633:toxicity*; D011247:Pregnancy; D011401:Promoter Regions, Genetic; D016271:Proto-Oncogene Proteins c-myc / Q000502:physiology; D018336:Receptors, Aryl Hydrocarbon / Q000187:drug effects / Q000502:physiology; D019098:Telomerase / Q000378:metabolism*; D013723:Teratogens / Q000633:toxicity*; D014407:Tumor Cells, Cultured; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000235:genetics* / Q000473:pathology
D004268:DNA-Binding Proteins; C489427:MYC protein, human; D000072317:Polychlorinated Dibenzodioxins; D016271:Proto-Oncogene Proteins c-myc; D018336:Receptors, Aryl Hydrocarbon; D013723:Teratogens; D004958:Estradiol; D019098:Telomerase